Title
Successes and challenges of HIV prevention in men who have sex with men
Date Issued
01 January 2012
Access level
open access
Resource Type
review
Author(s)
Sullivan P.S.
Carballo-Diéguez A.
Coates T.
Goodreau S.M.
McGowan I.
Sanders E.J.
Smith A.
Goswami P.
Sanchez J.
Publisher(s)
Elsevier B.V.
Abstract
Men who have sex with men (MSM) have been substantially affected by HIV epidemics worldwide. Epidemics in MSM are re-emerging in many high-income countries and gaining greater recognition in many low-income and middle-income countries. Better HIV prevention strategies are urgently needed. Our review of HIV prevention strategies for MSM identified several important themes. At the beginning of the epidemic, stand-alone behavioural interventions mostly aimed to reduce unprotected anal intercourse, which, although somewhat efficacious, did not reduce HIV transmission. Biomedical prevention strategies reduce the incidence of HIV infection. Delivery of barrier and biomedical interventions with coordinated behavioural and structural strategies could optimise the effectiveness of prevention. Modelling suggests that, with sufficient coverage, available interventions are sufficient to avert at least a quarter of new HIV infections in MSM in diverse countries. Scale-up of HIV prevention programmes for MSM is difficult because of homophobia and bias, suboptimum access to HIV testing and care, and financial constraints.
Start page
388
End page
399
Volume
380
Issue
9839
Language
English
OCDE Knowledge area
Enfermedades infecciosas Ciencias socio biomédicas (planificación familiar, salud sexual, efectos políticos y sociales de la investigación biomédica)
Scopus EID
2-s2.0-84864285679
PubMed ID
Source
The Lancet
ISSN of the container
01406736
Sponsor(s)
We thank Jeb Jones and Adam Vaughan for their assistance with preparation of figure 1 and the appendix , Wayne Johnson for his assistance with calculation of effect sizes for published studies, the PUMA research team (principal investigator Susan Buchbinder), and Sharoda Dasgupta and Kathryn Risher for their assistance with developing input parameters for the modelling. PSS was supported by the National Institutes of Health ( NIMH: R01-MH85600; NIMHHD: RC1- MD004370; NIAID: R01-AI094575; NICHD: R01-HD067111 ) and the Emory Center for AIDS Research ( P30-AI050409 ), SMG by Prevention Umbrella for MSM in the Americas ( National Institute of Allergy and Infectious Diseases , R01-AI083060 ) and the American Foundation for AIDS Research, EJS by the International AIDS Vaccine Initiative, and PG by Avahan, the Indian initiative of the Bill & Melinda Gates Foundation.
Sources of information: Directorio de Producción Científica Scopus